David Shenker
Obstetrics & Gynecology · Little Rock, ARNPI 1578511473
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $23,761 of the $27,633 with a category attached, or 86.0%. Organon accounts for 86.6% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2023 at $13,937 and has fallen 99.8% since, to $31 in 2025. Among obstetrics & gynecology clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 188 payments — averaging $146.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$24K
- Johnson & Johnson$1K
- AbbVie$532
- Merz North America, Inc.$369
- Pfizer$194
- Therapeuticsmd, Inc.$147
- plus $1K from 21 others
What the payments were for
- Consulting fees$3401%
- Speaking & faculty fees$23,76186%
- Food & beverage$3,51213%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 27 | $23,928 |
| Johnson & Johnson(2 entities) | 53 | $1,284 |
| AbbVie(2 entities) | 28 | $532 |
| Merz North America, Inc. | 1 | $369 |
| Pfizer | 15 | $194 |
| Therapeuticsmd, Inc. | 3 | $147 |
| Lupin Inc. | 3 | $144 |
| Bayer | 6 | $124 |
| Intuitive Surgical | 2 | $121 |
| Myovant Sciences Inc. | 7 | $117 |
| Mayne Pharma Commercial LLC | 4 | $78 |
| Duchesnay USA Incorporated | 6 | $76 |
| Exeltis, USA Inc. | 4 | $63 |
| Evofem Biosciences, Inc. | 4 | $58 |
| Mylan Pharmaceuticals Inc. | 4 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Hologic Sales And Service, LLC | 3 | $44 |
| Avion Pharmaceuticals | 3 | $44 |
| Coloplast | 3 | $41 |
| Agile Therapeutics, Inc. | 2 | $31 |
| Minerva Surgical, Inc | 2 | $26 |
| BD | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Radius Health, Inc. | 1 | $16 |
| Merck | 1 | $13 |
| Sage Therapeutics, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$23,761
- Lapra-TY$340
- LIGACLIP$340
- LIGAMAX$340
- STRATAFIX$340
- Humira$125
- PDS II (polydioxanone) Suture$125
- DERMABOND Portfolio$125
- SOLOSEC$115
- BIJUVA$114
- Da Vinci Surgical System$101
How this compares
$27,633 in reported general payments places this provider in the 95th percentile of 272 obstetrics & gynecology providers in Arkansas.
Other obstetrics & gynecology in Little Rock
- Michael CopeLittle Rock$147K
- Julia GoodwinLittle Rock$16K
- Ananth RanganathanLittle Rock$11K
- Mary RacherLittle Rock$11K
- Nirvana ManningLittle Rock$10K
- Sharai AmayaLittle Rock$9K
- Emily WilliamsLittle Rock$9K
- Shelly GibbsLittle Rock$8K
- Stacy Ulmer-PinterLittle Rock$8K
- Leticia JonesLittle Rock$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.